most common cancer in younger men ages between 15 45 with over 2,300 cases diagnosed per year
98% cure rates are possible if found at an early stage
Even when testicular cancer has spread to other areas of the body, cure can still be achieve St. Bartholomews Hospital, London www.orchid-cancer.org.uk
Number of New Cases and Deaths per 100,000 from 1992-2011
Estimated New Cases in 2014 8,820 % of All New Cancer Cases 0.5% National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program Estimated Deaths in 2014 380 % of all cancer deaths 0.1% Relative Survival of 5yrs or more after Diagnosis of Testicular Cancer National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program
Percent Surviving 5 Years 95.3 % Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Testis Cancer National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program
Localized (68%) Confined to Primary Site Regional (18%) Spread to Regional Lymph Nodes Distant (12%) Cancer Has Metastasized Unknown (1%) Unstaged Compared to other cancers, testis cancer is rare Common Types of Cancer Estimated New Cases 2014 Estimated Deaths 2014 Prostate Cancer 233,000 29,480 Breast Cancer (Female) 232,670 40,000 Lung and Bronchus Cancer 224,210 159,260 Colon and Rectum Cancer 136,830 50,310 Melanoma of the Skin 76,100 9,710 Bladder Cancer 74,690 15,580 Non-Hodgkin Lymphoma 70,800 18,990 Kidney and Renal Pelvis Cancer 63,920 13,860 Thyroid Cancer 62,980 1,890 Endometrial Cancer 52,630 8,590 - - - Testis Cancer 8,820 380 National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program
Testis cancer represents 0.5% of all new cancer cases 0.5% Background: Incidence GCTs are the most common solid tumors in men between the ages of 15 and 35 years. In a man aged 50 or older, a solid testicular mass should be regarded as lymphoma until proven otherwise. Devita, Hellman & Rosenberg's Cancer: Principles & Practice of Oncology, 8th Edition Percent of New Cases by Age Group: Testis Cancer National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program
Median Age At Diagnosis 33 Testis cancer is most frequently diagnosed among men aged 20-34. Percent of Deaths by Age Group: Testis Cancer National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program
Median Age At Death 41 The percent of testis cancer deaths is highest among men aged 20-34. Number of New Cases per 100,000 Persons by Race/Ethnicity: Testis Cancer National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program
Epidemiology: Familial clustering has been observed, particularly among siblings. Studies have failed to identify an association between vasectomy, diethylstilbestrol exposure, trauma, or viral infection, and GCT. More recently, testicular cancer has been reported in men infected with HIV; however, few data support a higher incidence of GCT in HIV- infected individuals, and the results of treatment are similar. Devita, Hellman & Rosenberg's Cancer: Principles & Practice of Oncology, 8th Edition Epidemiology: Philippines Cases of testicular and prostate cancers, which are the leading cause of cancer deaths in men 20-35yo and second most common cancer in men are increasingly becoming a cause for concern 14 th Congress of the Republic of the Philippines http://www.senate.gov.ph/ Epidemiology: Philippines In the study M.T.M. Redaniel, A.V. Laudico, et.al., Cancer in the Philippines
From a total of 27, 130 male subjects from Metro Manila & Rizal Provinces, 248 (0.9%) had testicular tumor
Vol. IV Part 1 Cancer incidence 1998-2002
Possible Risk Factors: Cryptorchidism Carcinoma in situ Brother/father w/ testicular CA Previous history of testicular CA Sedentary lifestyle Repeated trauma (rather than inevitable knocks) Smoking marijuana Men with HIV are up to twice as likely to develop testicular CA
St. Bartholomews Hospital, London www.orchid-cancer.org.uk
Cryptorchidism Associated with several-fold higher risk of GCT Abdominal cryptorchid testis are at higher risk than inguinal cryptorchid testis Orchidopexy should be performed before puberty Early orchidopexy reduces the risk of GCT and improves the ability to save the testis Longo, Fauci, et.al. Harrisons Principles of Internal Medicine 18 th ed, 2012 Cryptorchidism Associated with 10% of testicular GCTs The most important risk factor Part of a spectrum of d/o known as testicular dysgenesis syndrome (TDS): Cryptorchidism Hypospadias Poor sperm quality
Kumar, Abbas, Fausto, Aster Robbins & Cotran Pathologic Basis of Disease 8 th ed Cryptorchidism In the cohort study by Pettersson et.al., on men who underwent orchiopexy for undescended testis at Sweden between 1964- 1999, they determined the age at treatment for undescended testis and the risk of testicular cancer They concluded that, treatment for undescended testis before puberty decreases the risk of testicular cancer Age at surgery for undescended testis and risk of testicular cancer http://www.ncbi.nlm.nih.gov/pubmed
Cryptorchidism In the systematic review & meta-analysis by Walsh TJ, et.al., determines whether orchiopexy affects the natural history of testicular cancer development They concluded that, early surgical intervention is indicated in children with cryptorchidism Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer 2007 http://www.ncbi.nlm.nih.gov/pubmed
Marijuana Use In a case control study, researchers found that men with testicular tumors were about twice as likely to have a history of using marijuana. Most of the increased risk was found in men with a germ cell tumor sub-type called non- seminomas. American Cancer Society 2012 http://www.cancer.org/cancer/news/study- links-marijuana-use-to-testicular-cancer Possible Risk Factors: Cryptorchidism Carcinoma in situ Brother/father w/ testicular CA Previous history of testicular CA Sedentary lifestyle Repeated trauma (rather than inevitable knocks) Smoking marijuana Men with HIV are up to twice as likely to develop testicular CA
St. Bartholomews Hospital, London www.orchid-cancer.org.uk
Genetics Longo, Fauci, et.al. Harrisons Principles of Internal Medicine 18 th ed, 2012
i12p Pathognomonic of GCT of all histologic types Histologic Types St. Bartholomews Hospital, London www.orchid-cancer.org.uk
Most are aggressive cancers Generally, benign Clinical Presentation Painless testicular mass Testicular discomfort/swelling Backpain Dyspnea Gynecomastia Longo, Fauci, et.al. Harrisons Principles of Internal Medicine 18 th ed, 2012
Painless testicular mass Swelling (orchitis/epididymitis)
Trial of antibiotics
Ultrasound Persistence
(+) Mass Radical inguinal orchiectomy Longo, Fauci, et.al. Harrisons Principles of Internal Medicine 18 th ed, 2012
(+) Mass Radical inguinal orchiectomy
CXR, CT of abd & pelvis
Longo, Fauci, et.al. Harrisons Principles of Internal Medicine 18 th ed, 2012
Staging Includes determination serum AFP hCG LDH Longo, Fauci, et.al. Harrisons Principles of Internal Medicine 18 th ed, 2012
Staging St. Bartholomews Hospital, London www.orchid-cancer.org.uk
Staging St. Bartholomews Hospital, London www.orchid-cancer.org.uk
St. Bartholomews Hospital, London www.orchid-cancer.org.uk
St. Bartholomews Hospital, London www.orchid-cancer.org.uk
Choriocarcinoma Pathology Nonseminomatous GCTs Endodermal sinus tumor (yolk-sac tumor) Assoc w/ secretion of AFP Most common in infants & children up to 3yo Good prognosis Usually mixed w/ embryonal CA Yolk-sac tumor
Pathology Nonseminomatous GCTs Pure Embryonal Carcinoma May secrete AFP or hCG or both Mostly in 20-30 age group More aggressive than seminomas Embryonal Carcinoma Pathology Nonseminomatous GCTs Teratoma Composed of somatic cell types derived from 2 or more germ layers Occur at any age Teratoma Pathology Seminomatous GCTs Seminoma 50% of all GCTs Peak at 30s, never occurred in infants More indolent clinical course 70% pt presents w/ stage I disease Lung & visceral metastasis are rare Seminoma Treatment Longo, Fauci, et.al. Harrisons Principles of Internal Medicine 18 th ed, 2012